Just found another article by same person published very recently on Jan 1st 2016,
He mentioned below,
"As I mentioned, there were a few companies that I got very wrong. Anatara (ASX : ANR) and Oncosil (ASX : OSL) are the two standouts, along with Imuron (ASX : IMC) and ResApp (ASX : RAP). I don’t consider any of these companies to be investment-worthy and so I would never have put my hard-earned cash into any of them anyhow. But obviously other people did, and did very well in some instances."
Just found another article by same person published very...
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
Add to My Watchlist
What is My Watchlist?